Fortitude Family Office’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$454 Hold
26
﹤0.01% 1764
2025
Q4
$510 Sell
26
-153
-85% -$3.17K ﹤0.01% 1704
2025
Q3
$4.93K Sell
179
-17
-9% -$523 ﹤0.01% 815
2025
Q2
$5.98K Buy
+196
New +$5.57K ﹤0.01% 732

Other funds holding USNA

Fortitude Family Office's USNA Position: Q1 2026 in Review

Fortitude Family Office held its Usana Health Sciences (USNA) position steady in Q1 2026 at 26 shares worth $454. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Fortitude Family Office first reported a position in USNA in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.98K in Q2 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Fortitude Family Office held 26 shares of Usana Health Sciences worth $454 as of Q1 2026.
  • Fortitude Family Office left its Usana Health Sciences share count unchanged in Q1 2026.
  • Usana Health Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1764 holding.
  • Fortitude Family Office first reported a position in Usana Health Sciences in Q2 2025 and has held it in 4 quarters since.
  • Fortitude Family Office's Usana Health Sciences position peaked at $5.98K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.